News about Consultants

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

Pharma major Lupin Limited (Lupin) announced today the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.

Consultants | 13/08/2020 | By Darshana

VJ Farma seeks DCGI?s nod to import 5,000 remdesivir vials from Bangladesh for COVID-19 patients in Maharashtra

VJ Farma seeks DCGI?s nod to import 5,000 remdesivir vials from Bangladesh for COVID-19 patients in Maharashtra

Even as the number of COVID-19 cases in Maharashtra is increasing with each passing day and urgently needs remdesivir injections for critically ill patients, the Mumbai-based VJ Farma has sought no objection certificate (NOC) from Drugs Controller General of India (DCGI) for importing 5,000 remdesivir vials from a Bangladesh firm Eskayef Pharmaceuticals

Consultants | 09/07/2020 | By Darshana

Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily

Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily

Thyrocare, India?s leading diagnostic laboratory chain, has announced the availability of ?COVID Antibody Test? to check your body?s response to COVID-19 infection. It is not a diagnostic test, but is used for sero-surveillance to understand whether a person has encountered the infection in the recent past

Consultants | 05/07/2020 | By Darshana

FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials

FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials

The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the FDA?s Oncology Center of Excellence (OCE). Through a new website, Project Patient Voice creates a consistent source of publicly available information describing patient-reported symptoms from cancer trials

Consultants | 24/06/2020 | By Darshana

FDA Approves Drug to Treat Infants and Children with HIV

FDA Approves Drug to Treat Infants and Children with HIV

Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments

Consultants | 15/06/2020 | By Darshana

Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns

Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday

Consultants | 26/05/2020 | By Darshana

DRDO introduces two new products to enhance operations during COVID-19 disinfection process

DRDO introduces two new products to enhance operations during COVID-19 disinfection process

The Defence Research and Development Organisation (DRDO) has introduced two products which can enhance the operations at public places during the COVID-19 disinfection process

Consultants | 19/04/2020 | By Darshana


We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology